Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Intra-cellular Therapies, Inc.

Clinical trials sponsored by Intra-cellular Therapies, Inc., explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

Biopharma developing CNS treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 10 Not yet recruiting 1 Completed 13

Can a new pill ease depression without Add-Ons?

Disease control Not yet recruiting

This phase 3 trial is testing whether lumateperone (Caplyta), taken alone, can reduce symptoms of major depressive disorder (MDD) compared to a placebo. About 585 adults with MDD will receive one of two doses of lumateperone or a placebo for six weeks, followed by a long-term ext…

Phase: PHASE3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC